Sale!

Liver Kidney Microsomal LKM Antibody in Dilutions IFA Test Cost

Original price was: 810 د.إ.Current price is: 730 د.إ.

-10%

The Liver Kidney Microsomal (LKM) Antibody in Dilutions IFA Test is a specialized diagnostic tool used to detect the presence of LKM antibodies in the blood. These antibodies are primarily associated with autoimmune liver diseases, such as autoimmune hepatitis type 2, where the body’s immune system mistakenly attacks liver cells, causing inflammation and damage. The test employs the Indirect Fluorescent Antibody (IFA) technique, which involves tagging antibodies with a fluorescent dye that can be visualized under a microscope, providing a qualitative assessment of the antibodies.

Performed at DNA Labs UAE, a leading laboratory with state-of-the-art facilities, this test is crucial for the accurate diagnosis and management of autoimmune liver conditions. It helps in distinguishing between different types of autoimmune hepatitis and in planning the appropriate treatment strategy. The cost of the Liver Kidney Microsomal (LKM) Antibody in Dilutions IFA Test at DNA Labs UAE is 730 AED. Given the complexity of autoimmune liver diseases and the need for precise diagnosis, this test is an essential tool in the arsenal of healthcare providers, offering reliable results for patients experiencing symptoms of liver dysfunction.

Description

LIVER KIDNEY MICROSOMAL LKM ANTIBODY IN DILUTIONS IFA Test

Test Name: LIVER KIDNEY MICROSOMAL LKM ANTIBODY IN DILUTIONS IFA Test

Components: Price: 730.0 AED

Sample Condition: 3 mL (1.5 mL min.) serum from 1 SST. Ship refrigerated or frozen.

Report Delivery: Sample Daily by 11 am; Report Next day

Method: Immunofluorescence Assay

Test type: Disorders of Liver

Doctor: Gastroenterologist

Test Department: IMMUNOPATHOLOGY

Pre Test Information: No special preparation required

Test Details:

The LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY IN DILUTIONS IFA test is a laboratory test used to detect the presence of LKM antibodies in a patient’s blood. LKM antibodies are autoantibodies that target liver and kidney microsomes, which are small structures found within liver and kidney cells.

This test is performed using the Indirect Immunofluorescence Assay (IFA) method. In this test, the patient’s blood sample is diluted and then exposed to a substrate containing liver and kidney microsomes. If LKM antibodies are present in the blood, they will bind to the microsomes.

After washing away any unbound antibodies, a fluorescently-labeled secondary antibody is added. This secondary antibody binds to the patient’s LKM antibodies, forming a complex. The complex is then visualized under a fluorescent microscope. The intensity and pattern of fluorescence observed can provide information about the presence and quantity of LKM antibodies.

A positive result indicates the presence of LKM antibodies, which is associated with autoimmune liver diseases such as autoimmune hepatitis type 2.

It is important to note that the LKM antibody test is just one tool in the diagnosis of autoimmune liver diseases, and it should be interpreted in conjunction with other clinical and laboratory findings. A healthcare provider will use the results of this test, along with other tests and medical history, to make a diagnosis and determine appropriate treatment.

Test Name	LIVER KIDNEY MICROSOMAL LKM ANTIBODY IN DILUTIONS IFA Test
Components
Price	730.0 AED
Sample Condition	3 mL (1.5 mL min.) serum from 1 SST. Ship refrigerated or frozen.
Report Delivery	Sample Daily by 11 am; Report Next day
Method	Immunofluorescence Assay
Test type	Disorders of Liver
Doctor	Gastroenterologist
Test Department:	IMMUNOPATHOLOGY
Pre Test Information	No special preparation required
Test Details	The LIVER KIDNEY MICROSOMAL (LKM) ANTIBODY IN DILUTIONS IFA test is a laboratory test used to detect the presence of LKM antibodies in a patient’s blood. LKM antibodies are autoantibodies that target liver and kidney microsomes, which are small structures found within liver and kidney cells. This test is performed using the Indirect Immunofluorescence Assay (IFA) method. In this test, the patient’s blood sample is diluted and then exposed to a substrate containing liver and kidney microsomes. If LKM antibodies are present in the blood, they will bind to the microsomes. After washing away any unbound antibodies, a fluorescently-labeled secondary antibody is added. This secondary antibody binds to the patient’s LKM antibodies, forming a complex. The complex is then visualized under a fluorescent microscope. The intensity and pattern of fluorescence observed can provide information about the presence and quantity of LKM antibodies. A positive result indicates the presence of LKM antibodies, which is associated with autoimmune liver diseases such as autoimmune hepatitis type 2. It is important to note that the LKM antibody test is just one tool in the diagnosis of autoimmune liver diseases, and it should be interpreted in conjunction with other clinical and laboratory findings. A healthcare provider will use the results of this test, along with other tests and medical history, to make a diagnosis and determine appropriate treatment.